BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
1.610
-0.230 (-12.50%)
Apr 20, 2026, 10:04 AM EDT - Market open
BiomX Market Cap
BiomX has a market cap or net worth of $2.57 million as of April 20, 2026. Its market cap has decreased by -83.66% in one year.
Market Cap
2.57M
Enterprise Value
8.41K
1-Year Change
-83.66%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $2.57M, a decrease of -99.87%. That is a compound annual growth rate of -62.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.93M | 2.72% |
| Dec 31, 2025 | 2.85M | -78.49% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Azitra | 3.48M |
| Enveric Biosciences | 3.44M |
| GeoVax Labs | 3.26M |
| Matinas BioPharma Holdings | 3.20M |
| Oragenics | 3.10M |
| Decoy Therapeutics | 3.09M |
| Calidi Biotherapeutics | 3.04M |
| Virax Biolabs Group | 2.99M |